Skip to content

Restoring Oscillatory Dynamics in Alzheimer’s Disease: A Laminar Whole-Brain Model of Serotonergic Psychedelic Effects

Jan C. Gendra, Edmundo Lopez-Sola, Francesca Castaldo, Èlia Lleal-Custey, Roser Sanchez-Todo, Jakub Vohryzek, Ricardo Salvador, Ralph G. Andrzejak, Giulio Ruffini, The Alzheimer’s Disease Neuroimaging Initiative

bioRxiv (Cold Spring Harbor Laboratory) December 16, 2024 preprint DOI: 10.1101/2024.12.15.628565 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort with computational modeling
Sample size 30
Population Subjects diagnosed with mild to moderate Alzheimer's disease
Topics Serotonin
Keywords Disease Dynamics music Laminar flow
Citations 7
Key findings Simulated serotonin 2A receptor activation reproduces EEG changes (alpha suppression, gamma enhancement) that correlate with receptor distribution and suggest restored network function in Alzheimer's disease.

Abstract

Abstract Classical serotonergic psychedelics show promise in addressing neurodegenerative disorders such as Alzheimer’s disease by modulating pathological brain dynamics. However, the precise neurobiological mechanisms underlying their effects remain elusive. This study introduces a personalized whole-brain model built upon a laminar neural mass framework to elucidate these effects. Using multimodal neuroimaging data from thirty subjects diagnosed with mild to moderate Alzheimer’s disease, we simulate the impact of serotonin 2A receptor activation, characteristic of psychedelics, on cortical dynamics. By modulating the excitability of layer 5 pyramidal neurons, our models reproduce hallmark changes in EEG power spectra observed under psychedelics, including alpha power suppression and gamma power enhancement. These spectral shifts are shown to correlate strongly with the regional distribution of serotonin 2A receptors. Furthermore, simulated EEG reveals increased complexity and entropy, suggesting restored network function. These findings underscore the potential of serotonergic psychedelics to reestablish healthy oscillatory dynamics in the prodromal and early phases of Alzheimer’s disease and offer mechanistic insights into their potential therapeutic effects in neurodegenerative disorders.

Comparable studies

Other observational and cohort studies on serotonin, most cited first.

Study Year Design Participants
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Healthy volunteers 2019 Observational cohort n = 8
Memory impairment in abstinent MDMA ("Ecstasy") users Abstinent MDMA users 1998 Observational cohort
Dynamic coupling of whole-brain neuronal and neurotransmitter systems Healthy humans 2020 Observational study
The Serotonin System and Spiritual Experiences Normal male subjects, ages 20-45 years 2003 Observational cohort n = 15
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Healthy human participants 2018 Observational study with computational modeling

Citations in the library

Explore topics